Target expression details
Target General Information | |||||
---|---|---|---|---|---|
Target ID | T54582 | ||||
Target Name | Nicotinamide phosphoribosyltransferase | ||||
Synonyms | NAmPRTase; Nampt; PreB cellenhancing factor; PreBcell colonyenhancing factor 1; Visfatin; NAMPT | ||||
Target Type | Clinical Trial | ||||
Gene Name | NAMPT | ||||
Biochemical Class | Pentosyltransferase | ||||
UniProt ID | NAMPT_HUMAN | ||||
Target Gene Expression Profiles in the Disease-Relevant Drug Targeted Tissue of the Patients and Healthy Individuals | |||||
Disease | Acute myelocytic leukemia | ||||
Example drug | Daporinad | Phase 2 | [529259], [542710], [1572592] | ||
Tissue | Bone marrow | ||||
Level of differential expression between the patients in the disease section of the tissue and the tissues of healthy individual | Fold-change: -0.63 Z-score: -0.59 P-value: 3.06E-08 |
||||
Target gene expression profiles of the patients in the disease section of the tissue
Target gene expression profiles in the tissue of healthy individual
|
|||||
Reference | |||||
Ref 542710 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7745). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.